ISCD Learning
Catalog Advanced Search
-
Both ACCME and ASRT Credits
Expires 10/14/2027: Vertebral augmentation is an effective minimally invasive treatment for patients suffering from painful osteoporotic vertebral compression fractures. This presentation will review evidence-based indications for vertebral augmentation, with emphasis on clinical and imaging factors that guide optimal patient selection. We will examine short- and long-term outcomes data, including expected pain relief, functional improvement, and possible procedural risks. Practical, case-based insights will be shared to aid in every day clinical decision-making. GLP-1 receptor agonists are now widely used for the management of diabetes and overweight/obesity. Concerns have been raised about their potential impact on skeletal muscle and bone density. This talk will look at the evidence to date regarding how this class of medication impacts bone and muscle health and will highlight future areas of investigation.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.5 ASRT Category A Credits
Activity Expires October 14, 2027Activity Description
Vertebral augmentation is an effective minimally invasive treatment for patients suffering from painful osteoporotic vertebral compression fractures. This presentation will review evidence-based indications for vertebral augmentation, with emphasis on clinical and imaging factors that guide optimal patient selection. We will examine short- and long-term outcomes data, including expected pain relief, functional improvement, and possible procedural risks. Practical, case-based insights will be shared to aid in every day clinical decision-making.
GLP-1 receptor agonists are now widely used for the management of diabetes and overweight/obesity. Concerns have been raised about their potential impact on skeletal muscle and bone density. This talk will look at the evidence to date regarding how this class of medication impacts bone and muscle health and will highlight future areas of investigation.Learning Objectives
- Highlight the clinical impact of osteoporotic vertebral compression fractures (VCFs) and how they contribute to functional decline and mortality.
- Discuss inclusion criteria for vertebral augmentation to help identify candidates for referral/intervention.
- Review expected outcomes of vertebral augmentation, including effects on pain relief, functional improvement, and safety.
- Evaluate the risks, limitations, and controversies surrounding vertebral augmentation, including interpretation of existing trial data.
- Review the mechanism of action and indications for glucagon-like peptide-1 (GLP-1) receptor agonists
- Examine the impact of GLP-1s on skeletal muscle mass and function
- Examine the impact of GLP-1s on bone density and fracture risk
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A Continuing Education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on October 15th, 2026.
Daniel J. Holzwanger, MD
Interventional Radiologist
Weill Cornell Medicine
Daniel J. Holzwanger, MD is an Interventional Radiologist and Assistant Professor of Clinical Radiology at Weill Cornell Medicine and New York-Presbyterian Hospital. He earned his medical degree from Weill Cornell Medical College and completed his Diagnostic Radiology residency at New York-Presbyterian/Weill Cornell Medical Center, where he served as Chief Resident. He subsequently completed fellowship training in Vascular and Interventional Radiology at Vanderbilt University Medical Center. His clinical practice focuses on image-guided musculoskeletal and spine interventions, including vertebral augmentation, tumor ablation, nerve ablation, and embolization therapies for pain and oncology care, with ongoing research aimed at advancing minimally invasive treatments for musculoskeletal and cancer-related pain.
Shirine E. Usmani, MD, PhD, FRCPC
Assistant Professor, Clinician Investigator and Staff Physician
University of Toronto, University Health Network, Toronto ON
Dr. Shirine Usmani completed her undergraduate degree in Physiology and Pharmacology at Western University before entering the MD/PhD program, also at Western. Her PhD focused on musculoskeletal health, specifically understanding molecular mechanisms involved in bone development and osteoarthritis. Dr. Usmani then went on to complete her residency training in Internal Medicine with a sub-specialization in Endocrinology at the University of Toronto. She completed a Post-Doctoral Fellowship through Toronto's Clinician Scientist Training Program with a focus on sarcopenia and genetic regulators of muscle mass. In October 2024 she started a full-time position as a Clinician Investigator/Assistant Professor at the University Health Network (UHN)/University of Toronto. Her research focuses on clinical and translational research through the UHN Osteoporosis and Metabolic Bone clinic.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- Clinician Member - $25
- Technologist Member - $25
- Resident/Student/Fellow/Retired Membership - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
Both ACCME and ASRT Credits
Expires 10/14/2027: Estimating fracture risk should be an integral part of bone health assessment. Multiple tools and strategies are available - some well validated, others more controversial but nonetheless potentially useful. We'll try to explore as many avenues as possible to get the fullest understanding of fracture risk for treatment recommendation. The second presentation will first review the principle behind TBS, and why it correlates with other measures of trabecular bone microarchitecture and bone strength. We will review the effects of degenerative changes, fracture and other artifacts on TBS values. We will then review how the addition of TBS can alter fracture risk assessment and highlight clinical scenarios where the addition of TBS may alter fracture risk management decisions.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.25 ASRT Category A Credits
Activity Expires October 14, 2027Activity Description
Estimating fracture risk should be an integral part of bone health assessment. Multiple tools and strategies are available - some well validated, others more controversial but nonetheless potentially useful. We'll try to explore as many avenues as possible to get the fullest understanding of fracture risk for treatment recommendation. The second presentation will first review the principle behind TBS, and why it correlates with other measures of trabecular bone microarchitecture and bone strength. We will review the effects of degenerative changes, fracture and other artifacts on TBS values. We will then review how the addition of TBS can alter fracture risk assessment and highlight clinical scenarios where the addition of TBS may alter fracture risk management decisions.
Learning Objectives
- Understand the rationale(s) for risk stratification in osteoporosis
- Review some scientific aspects of commonly utilized risk stratification tools
- Appreciate some additional available resources to individualize fracture risk profiles
- Explore near-term novel approaches to risk stratification
- Understand the associations of TBS with incident hip and major osteoporotic fractures, and the practical effect measurement of TBS has on FRAX fracture prediction
- Understand the circumstances under which vertebrae may need to be removed from BMD measurement but not TBS
- Understand expected changes of TBS vs BMD with osteoporosis drug therapy
- Understand how changes in scan type and tissue thickness between current and prior DXA studies may artefactually create apparent changes in TBS measurement values
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.25 Category A Continuing Education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on October 15th, 2026.
Christopher Shuhart, MD, MHA, CCD
Instructor, Department of Family Medicine and Geriatrics Fellowship
Swedish Medical Center
Dr. Shuhart was the founder and director of the Bone Health and Osteoporosis Center at Swedish Medical Group in Seattle, Washington. He is Past-President of the International Society for Clinical Densitometry (ISCD) 2019-2020. He is a co-author on the ISCD’s 2016 publication of “Best Practices” in the Journal of Clinical Densitometry, and was Co-Chair and Executive Author for the 2019 and 2023 ISCD Position Development Conferences.
Dr. Shuhart is now retired from clinical practice but continues to be active in teaching and training of residents, fellows and APC’s.
Dr. Shuhart received his medical degree from Dartmouth Medical School in 1987, and his Masters in Health Administration from the University of Washington in 2009. He is board certified in Family Medicine since 1990.
John Schousboe, MD, PhD, CCD
Health Services Researcher
HealthPartners Institute
Dr. Schousboe is a health services researcher at HealthPartners Institute and past director of the bone densitometry center of Park Nicollet Clinic, a large integrated health care delivery system the Twin Cities, Minnesota. He is a Past President of the International Society of Clinical Densitometry (ISCD) and a Fellow of the American Society of Bone and Mineral Research (ASBMR). During a 20 year research career, he has been an author on over 250 peer-reviewed publications. His contributions to science include studies of the accuracy, prevalence, clinical impact, and cost-effectiveness of vertebral fracture assessment, identification and prognostic significance of abdominal aortic calcification identification on lateral spine bone density images, trabecular bone score in older men, and associations of fractures, frailty, physical performance, sleep disturbances, and cognitive impairment with total health care costs.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- Clinician Member - $25
- Technologist Member - $25
- Resident/Student/Fellow/Retired Membership - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
Both ACCME and ASRT Credits
Expires 11/1/2027: This session will examine barriers to accessing bone density testing from a DXA technologist's perspective, with particular attention to patient populations who may be at increased risk for poor bone health but are not routinely referred for testing under current diagnostic ordering criteria or access to general healthcare. Participants will explore population-level factors that limit access to DXA services, including geographic, logistical, and health system constraints, as well as the impact of centralized scanning models and delayed scheduling on timely diagnosis and management. The session will also provide an overview of available peripheral and alternative bone assessment technologies—such as peripheral DXA (pDXA), quantitative ultrasound (QUS), and CT-derived bone mineral density—highlighting their potential role, strengths, and limitations in supporting bone health assessment and clinical decision-making when standard DXA access is limited.
Activity approved for 1.5 ASRT Category A Credits
Activity Expires November 1, 2027Activity Description
This session will examine barriers to accessing bone density testing from a DXA technologist's perspective, with particular attention to patient populations who may be at increased risk for poor bone health but are not routinely referred for testing under current diagnostic ordering criteria or access to general healthcare. Participants will explore population-level factors that limit access to DXA services, including geographic, logistical, and health system constraints, as well as the impact of centralized scanning models and delayed scheduling on timely diagnosis and management. The session will also provide an overview of available peripheral and alternative bone assessment technologies—such as peripheral DXA (pDXA), quantitative ultrasound (QUS), and CT-derived bone mineral density—highlighting their potential role, strengths, and limitations in supporting bone health assessment and clinical decision-making when standard DXA access is limited.
Learning Objectives
- Explain population-level challenges affecting access to DXA services.
- Recognize limitations associated with centralized DXA scanning and delayed scheduling.
- Describe the advantages and limitations of peripheral and alternative bone density assessment technologies, including pDXA, QUS, and CT-derived BMD.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on October 15th, 2026.
Kyla Kent, BA, CBDT
Technical Director
SAMBA Lab, Stanford University School of Medicine
Kyla Kent, BA, CBDT has been with Stanford University School of Medicine since 1991 in Adult Endocrine, Stanford Prevention Research Center and lastly as Technical Director of the Stanford Assessments of Muscle and Bone across the ages (SAMBA) Lab under the department of Pediatrics. Responsibilities include clinical facility management, protocol development, supervision of clinical staff, performance of DXA, HRpQCT, Biodex, functional strength assessments and other measures related to research conducted in the areas of childhood and adolescent bone health, bone metabolism, structural assessment, body composition, exercise, sleep, sarcopenia and healthy aging. Ms. Kent is a consultant in study design and instructor in bone density related imaging modalities for both the Palo Alto VA Hospital and Stanford Hospital, Stanford Children’s Hospital and the Stanford School of Medicine and internationally for bone mass measurement technique and analysis in growing skeletons. Ms. Kent is an active member of the International Society for Clinical Densitometry (ISCD). She joined at its beginning, did take a short hiatus and rejoined when ISCD met in San Francisco to be on the test committee. She has served on many committees over the years and currently is chair of the 2026 Tech symposium, serves on the pediatric and body composition faculties and Ask an Expert. She has served on the Facility Accreditation committee since its inception in 2011. She has acted as the Director, clinical instructor and lecturer for one of the few California certified, Limited License x-ray permit in DXA training program in Oakland, CA.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - Free!
- Clinician Member - Free!
- Technologist Member - Free!
- Resident/Student/Fellow/Retired Membership - Free!
- MOC Only - Free!
- Community Member - $35
- Professional Member - Free!
- More Information
-
Both ACCME and ASRT Credits
Expires 10/14/2027: Interactive session on the topic of optimizing the sequence of osteoporosis therapies for maximum benefit.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.5 ASRT Category A Credits
Activity Expires October 14, 2027Activity Description
Interactive session on the topic of optimizing the sequence of osteoporosis therapies for maximum benefit.
Learning Objectives
- Evaluate the clinical evidence supporting the initiation of treatment with osteo-anabolic drugs rather than anti-resorptive drugs for patients at very high or imminent risk of fracture.
- Identify the pharmacological "off-sets" of different osteoporosis therapies.
- Implement effective transition protocols when moving from one therapy class to another, with a specific focus on the mandatory follow-up for denosumab and anabolic therapies.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on October 15th, 2026.
Sabashini Ramchand, MBBS
Staff Endocrinologist
Cleveland Clinic
Dr. Sabashini Ramchand is a Staff Endocrinologist at the Cleveland Clinic and an Assistant Professor at the Lerner College of Medicine – Case Western Reserve University. As a clinician-researcher, she is an emerging leader in the field of metabolic bone disease, notably serving as the Clinical Co-Chair for the ASBMR 2023 Annual Meeting. Her primary research and clinical interests involve the optimization of medical therapies for osteoporosis, including the strategic use of combination and sequential treatment regimens, as well as the optimization of skeletal health in patients experiencing bone loss due to breast cancer treatments. Dr. Ramchand completed her medical training and endocrine fellowship in Melbourne, Australia, and then transitioned to a research fellowship at Massachusetts General Hospital, Harvard Medical School before she joined the Cleveland Clinic in 2024.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - Free!
- Clinician Member - Free!
- Technologist Member - Free!
- Resident/Student/Fellow/Retired Membership - Free!
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
Both ACCME and ASRT Credits
Expires 9/14/2027: Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD) is a complex disorder of bone and mineral metabolism that affects all patients with CKD, in particular as kidney dysfunction worsens. CKD-MBD is associated with abnormalities in the Vitamin D-Parathyroid axis and Osteoporosis. This session will review the epidemiology of CKD-MBD and its complications and strategies to diagnose and manage the disorder, with a focus on patient-centered outcomes.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.00 ASRT Category A Credits
Activity Expires September 14, 2027Activity Description
Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD) is a complex disorder of bone and mineral metabolism that affects all patients with CKD, in particular as kidney dysfunction worsens. CKD-MBD is associated with abnormalities in the Vitamin D-Parathyroid axis and Osteoporosis. This session will review the epidemiology of CKD-MBD and its complications and strategies to diagnose and manage the disorder, with a focus on patient-centered outcomes.
Learning Objectives
- Appreciate new definition of CKD-MBD
- Understand CKD-MBD from a patient-oriented perspective
- Learn a basic treatment approached to CKD-MBD
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.00 Category A Continuing Education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on September 15th, 2026.
Thomas L. Nickolas, MD, MS, FASN, FASBMR
Chief, David C. and Betty Farrell Professor of Medicine
Division of Bone and Mineral Diseases, Washington University School of Medicine
Dr. Nickolas is a Professor of Medicine and Chief of the Division of Bone and Mineral Diseases at the Washington University School of Medicine in St Louis. Dr. Nickolas received his medical degree from the University of Pittsburgh School of Medicine, trained in Internal Medicine at the University of Pennsylvania and in Nephrology at Columbia University. His primary interests are in the skeletal effects of kidney diseases. His lab focuses on redefining our understanding of and approach to bone disease in adults and children with kidney failure. He uses advanced and novel methods to phenotype the characteristics of bone and mineral diseases in CKD patients.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- Clinician Member - $25
- Technologist Member - $25
- Resident/Student/Fellow/Retired Membership - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
ASRT Category A Credits
Expires 10/1/2027: This session will introduce DXA technologists to emerging innovations that are shaping the future of bone densitometry, with an emphasis on artificial intelligence–enabled tools and data integration. Participants will examine how AI-driven quality-control processes and automated region-of-interest detection can enhance measurement consistency, workflow efficiency, and scalability across clinical settings. The program will also examine how DXA data can be linked with large clinical and research datasets to support advanced risk prediction, longitudinal monitoring, and population-level analysis. In addition, participants will discuss key research opportunities and critical knowledge gaps that must be addressed to advance next-generation DXA technologies and inform the evolving role of the DXA technologist.
Activity approved for 1.5 ASRT Category A Credits
Activity Expires October 1, 2027Activity Description
This session will introduce DXA technologists to emerging innovations that are shaping the future of bone densitometry, with an emphasis on artificial intelligence–enabled tools and data integration. Participants will examine how AI-driven quality-control processes and automated region-of-interest detection can enhance measurement consistency, workflow efficiency, and scalability across clinical settings. The program will also examine how DXA data can be linked with large clinical and research datasets to support advanced risk prediction, longitudinal monitoring, and population-level analysis. In addition, participants will discuss key research opportunities and critical knowledge gaps that must be addressed to advance next-generation DXA technologies and inform the evolving role of the DXA technologist.
Learning Objectives
- Recognize how AI-enabled quality control and automated region-of-interest detection can improve consistency, efficiency, and scalability of DXA measurements.
- Identify how DXA data can be linked with large clinical and research datasets to support risk prediction, longitudinal monitoring, and population-level analysis.
- Identify key research opportunities and critical gaps that must be addressed to advance the next generation of bone densitometry.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on September 15th, 2026.
John A. Shepherd, PhD, FAAPM, CCD
Professor/Chief Scientific Officer
University of Hawaii Cancer Center, Honolulu, HI
Dr. Shepherd is a Researcher/Professor at the University of Hawaii Cancer Center, a Fulbright Scholar, a Fellow of the American Institute for Medical and Biological Engineering (AIMBE), and a former President of the International Society for Clinical Densitometry. He received his PhD in Engineering Physics from the University of Virginia and then completed a Postdoctoral Fellowship in Biophysics at Princeton University. From there he went on to develop body composition and bone density algorithms for a major women’s health company and his patents are the basis for the accuracy of that company’s body composition algorithms. He then joined the Radiology Department of the University of California San Francisco and led his own research group for 19 years studying a wide variety of biomarkers for breast cancer, obesity and osteoporosis from medical imaging using advanced machine learning techniques. For the past 5 years, he has been with the University of Hawaii Cancer Center and is currently their Chief Scientific Officer. He also directs the UH Artificial Intelligence Precision Health Institute and the Hawaii Pacific Islands Mammography Registry. He has been continuously funded from the NIH since 2005, led 6 R01-funded studies, published over 350 peer-review publications that have been referenced over 23,000 times, and lastly is an avid surfer and island ridge hiker!
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- Clinician Member - $25
- Technologist Member - $25
- Resident/Student/Fellow/Retired Membership - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
Both ACCME and ASRT Credits
Expires 9/14/2027: This session will provide an overview of fractures from a radiology perspective. Real life cases will be shown. The imaging modalities covered include radiographs, MRI, and CT. The second lecture lecture reviews orthopedic surgical management of common fractures in patients with metabolic bone disease, using case examples of atypical femur fractures and osteoporotic pelvic ring injuries. The session emphasizes timely recognition, referral for operative evaluation, and surgical strategies that support mobilization and reduce risk of fracture progression or future injury.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.25 ASRT Category A Credits
Activity Expires September 14, 2027Activity Description
This session will provide an overview of fractures from a radiology perspective. Real life cases will be shown. The imaging modalities covered include radiographs, MRI, and CT. The second lecture lecture reviews orthopedic surgical management of common fractures in patients with metabolic bone disease, using case examples of atypical femur fractures and osteoporotic pelvic ring injuries. The session emphasizes timely recognition, referral for operative evaluation, and surgical strategies that support mobilization and reduce risk of fracture progression or future injury.
Learning Objectives
- Define stress fracture and identify common locations
- Understand the role of XR, CT, MRI, and bone scintigraphy
- Apply an evidence-based imaging algorithm for stress fracture evaluation
- Recognize atypical femur fractures in patients with metabolic bone disease, including key radiographic features, risk factors, and the importance of imaging the contralateral femur
- Identify when orthopedic referral or prophylactic fixation should be considered, particularly for incomplete or contralateral atypical femur fractures with symptoms or radiographic abnormalities
- Describe the evaluation and operative management considerations for osteoporotic pelvic ring injuries, including U-type sacral fractures, instability patterns, pain as a marker of instability, and the role of percutaneous screw fixation to improve mobilization
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.25 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on September 15th, 2026.
Erwin E. Xia, MD, CCD
Attending Radiologist
Hospital for Special Surgery
Erwin E. Xia, MD is an Attending Radiologist at Hospital for Special Surgery and Assistant Professor of Radiology at Weill Medical College of Cornell University. He completed his fellowship in Musculoskeletal Imaging and Intervention at Massachusetts General Hospital, Harvard Medical School and residency in Diagnostic Radiology at Thomas Jefferson University Hospital. His clinical interests include image-guided spine and joint interventional procedures, orthopedic sports imaging, and orthopedic oncology.
Kathryn Barth, MD
Trauma Surgeon
Hospital for Special Surgery
Dr. Kathryn Barth is an orthopedic surgeon specializing in the treatment of fractures in the upper and lower extremities, pelvis, and acetabulum. She has expertise in both operative and non-operative management of complex peri-articular fractures and post-traumatic problems such as deformity and non-unions (non-healing fractures).
Dr. Barth graduated summa cum laude from the University of Pennsylvania while graduating with honors in her major in Health & Societies: Health Care Markets & Finance and completing premedical requirements. She attended the Northwestern Feinberg School of Medicine in Chicago, IL where she graduated summa cum laude and was awarded the Clare Geigerich Award for Outstanding Promise in Orthopaedic Surgery. She was also inducted into the Alpha Omega Alpha Honors Society. She went on to complete her residency training in orthopedic surgery at the Hospital for Special Surgery where she served in leadership roles and received the Distinguished Housestaff Award upon graduation. She then completed a year-long fellowship at the University of Texas Health Science Center at Houston, one of the top training programs for orthopaedic trauma surgery in the country. She has also spent time abroad during her training learning about the reconstruction of complex traumatic injuries and non-unions at the Royal Brisbane & Women's Hospital in Australia and Korea University Guru Hospital in Seoul, South Korea.
Dr. Barth is also passionate about improving the care of trauma patients through clinical outcomes research. She has authored multiple peer-reviewed publications and presented research at numerous national research meetings. She is an active member of the American Academy of Orthopaedic Surgeons (AAOS) and the Orthopaedic Trauma Association (OTA).
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - Free!
- Clinician Member - Free!
- Technologist Member - Free!
- Resident/Student/Fellow/Retired Membership - Free!
- MOC Only - Free!
- Community Member - $35
- Professional Member - Free!
- More Information
-
Both ACCME and ASRT Credits
Expires 9/14/2027: The session will focus on imaging findings of metabolic and genetic disorders of childhood that affect bone mineral density. The session will review the impact of growth on the manifestation of metabolic disorders, and how these disorders affect bone formation. The session will also discuss the diagnosis by imaging of complications that can arise from abnormal bone metabolism in children.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.25 ASRT Category A Credits
Activity Expires September 14, 2027Activity Description
The session will focus on imaging findings of metabolic and genetic disorders of childhood that affect bone mineral density. The session will review the impact of growth on the manifestation of metabolic disorders, and how these disorders affect bone formation. The session will also discuss the diagnosis by imaging of complications that can arise from abnormal bone metabolism in children.
All images within the presentation are provided as a courtesy by Dr. Diego Jaramillo, MD, MPH, FACR
Learning Objectives
- Describe the key anatomic and imaging features of pediatric metabolic bone disease, including the roles of the physis, zone of provisional calcification, metaphysis, epiphysis, and periosteum in endochondral and intramembranous ossification.
- Differentiate common pediatric metabolic bone disorders on imaging, including rickets, renal osteodystrophy, hypophosphatasia, scurvy, osteogenesis imperfecta, lead toxicity, osteopetrosis, Gaucher disease, and mucopolysaccharidoses.
- Apply radiographic patterns to clinical diagnosis and management considerations, including recognizing disease distribution, distinguishing metabolic bone disease from trauma or non-accidental injury, and minimizing radiation exposure during pediatric imaging.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.25 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on September 15th, 2026.
Diego Jaramillo, MD, MPH, FACR
Attending Radiologist
Hospital for Special Surgery
Dr. Jaramillo is a pediatric radiologist specialized in imaging musculoskeletal disorders in children. He began his career as a pediatric radiologist at Massachusetts General Hospital and Boston Children’s Hospital at Harvard Medical School. From 2004 to 2015 he was Radiologist-in-Chief and Van Alen Chair of Radiology at The Children’s Hospital of Philadelphia and Professor of Radiology at the University of Pennsylvania School of Medicine. He has been a Vice Chair of Radiology at Stanford University and the Interim Chair of Radiology at Columbia University. He is currently the Director of Pediatric Imaging at the Hospital for Special Surgery and a Professor of Radiology at the Weill Cornell College of Medicine. He has been the President and Board Chair of the Society for Pediatric Radiology. His research has focused on the study of growth disorders using novel imaging technologies, mainly MRI-based, with both basic and transIational approaches. He has been the principal investigator of 3 major grants from the NIH. His current research focuses on studies of skeletal growth using diffusion tensor imaging of the physeal cartilage and newly formed metaphyseal bone, a technique he developed. He has published more than 170 peer reviewed publications and more than 100 reviews, chapters and case reports.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - Free!
- Clinician Member - Free!
- Technologist Member - Free!
- Resident/Student/Fellow/Retired Membership - Free!
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
ASRT Category A Credits
Expires 9/1/2027: This session will provide an in-depth, technologist-focused review of DXA acquisition and analysis variability across manufacturers, with emphasis on accurate region-of-interest (ROI) placement and interpretation for spine and hip examinations. Participants will examine common sources of technologist error, including suboptimal patient positioning, inappropriate post-acquisition analysis adjustments, and incorrect scan mode selection, and will learn strategies to prevent these pitfalls. The session will underscore the critical role of immediate scan review while the patient remains present, particularly for ensuring correct bone mapping and diagnostic integrity. In addition, participants will explore challenges related to serial comparability and review manufacturer-specific software glitches that may impact longitudinal bone density assessment.
Activity approved for 1.5 ASRT Category A Credits
Activity Expires September 1, 2027Activity Description
This session will provide an in-depth, technologist-focused review of DXA acquisition and analysis variability across manufacturers, with emphasis on accurate region-of-interest (ROI) placement and interpretation for spine and hip examinations. Participants will examine common sources of technologist error, including suboptimal patient positioning, inappropriate post-acquisition analysis adjustments, and incorrect scan mode selection, and will learn strategies to prevent these pitfalls. The session will underscore the critical role of immediate scan review while the patient remains present, particularly for ensuring correct bone mapping and diagnostic integrity. In addition, participants will explore challenges related to serial comparability and review manufacturer-specific software glitches that may impact longitudinal bone density assessment.
Learning Objectives
- Compare manufacturer-specific differences in region-of-interest (ROI) placement and analysis for spine and hip scans.
- Explain sources of technologist error including pitfalls of poor-quality positioning, inappropriate adjustments to the scan analysis, and improper scan mode selection.
- Recognize the importance of immediate scan review while the patient is present especially in the context of appropriate bone mapping.
- Describe serial comparability challenges and manufacturer-specific glitches.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on August 15th, 2026.
Wendy Tolman-Andrews, BS, RT(BD), CBDT
Radiologic Technologist
University of Connecticut - Farmington campus at UConn Health
Wendy Tolman-Andrews, BS, RT(BD), CBDT has been performing DXA bone densitometry since 1997. She’s a longtime active member of the ISCD on various committees and workgroups recently as part of “Ask an Expert”, Facility Accreditation, Patient Resources, and Strategic Planning. She is honored to have received the Sydney Bonnick Award, ISCD Technologist of the Year, and the Paul D. Miller Service Award. Wendy currently works at the University of Connecticut’s Farmington campus at UConn Health.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- Clinician Member - $25
- Technologist Member - $25
- Resident/Student/Fellow/Retired Membership - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
ASRT Category A Credits
Expires 9/1/2027: This educational session will provide a practical overview of current pharmacologic options for the prevention and treatment of osteoporosis. Participants will review commonly used bone medications and gain a clear understanding of how these therapies differ in their mechanisms of action on bone remodeling. The program will also address expected changes in bone mineral density associated with various treatments, including realistic timelines for achieving clinically meaningful improvement, to support informed decision-making and patient counseling.
Activity approved for 1.5 ASRT Category A Credits
Activity Expires September 1, 2027Activity Description
This educational session will provide a practical overview of current pharmacologic options for the prevention and treatment of osteoporosis. Participants will review commonly used bone medications and gain a clear understanding of how these therapies differ in their mechanisms of action on bone remodeling. The program will also address expected changes in bone mineral density associated with various treatments, including realistic timelines for achieving clinically meaningful improvement, to support informed decision-making and patient counseling.
Learning Objectives
- List current bone medications used for osteoporosis prevention and treatment.
- Differentiate the mechanisms of action of these medications on bone.
- Describe expected bone density changes and the time intervals required to observe clinically meaningful improvement.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on August 15th, 2026.
E. Michael Lewiecki, MD, FACP, FACE, CCD
Director
New Mexico Clinical Research & Osteoporosis Center, Inc.
E. Michael Lewiecki, MD, CCD, FACP, FACE, FASBMR, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health ECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. His is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies, and an educator with a special interest in the evaluation and treatment of osteoporosis and metabolic bone diseases. He has been principal investigator for many osteoporosis clinical trials and is author of over 300 publications in peer-reviewed medical journals, as well as books, book chapters, and online publications on osteoporosis. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD) and current president of the Osteoporosis Foundation of New Mexico (OFNM). He is an editor for Osteoporosis International, and is on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Densitometry. He has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award” and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation. Dr. Lewiecki is the program director of the annual Santa Fe Bone Symposium, the flagship activity of the OFNM.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- Clinician Member - $25
- Technologist Member - $25
- Resident/Student/Fellow/Retired Membership - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
